RANCHO CORDOVA, Calif., Nov. 13, 2012 (GLOBE NEWSWIRE) -- ThermoGenesis Corp. (Nasdaq:KOOL), a leading supplier of enabling technologies for the processing, storage and administration of cell therapies, today reported results for the first quarter of fiscal 2013.
